pharma news today glp-1 obesity drugs Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Therapies Drive Indian Pharma

Linagliptin is eliminated via a biliary route (10, 13, 15, 16)

Not only that, the GLP-1 drugs also quiet inflammation, stimulate the production of antioxidants, help repair damaged DNA, and slow the aging of the body's cells

Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al

A recent Survey of Ophthalmology review synthesized findings from cardiovascular outcomes trials, retrospective database analyses, meta-analyses and preclinical studies involving semaglutide, liraglutide, dulaglutide and related agents across six ocular conditions: diabetic retinopathy (DR), glaucoma, nonarteritic anterior ischemic optic neuropathy (NAION), age-related macular degeneration (AMD), idiopathic intracranial hypertension (IIH) and dry eye disease (DED)

Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery

Comparing Mounjaro to Other GLP-1 Treatments When comparing Mounjaro to established GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) , dulaglutide (Trulicity) , and liraglutide (Victoza, Saxenda) , several key differences emerge